Tulip BioMed, formerly known as Cell Bio-Systems, a developer of medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries, today announced it has filed for a provisional patent on its hydrophilic coating process, which affects the manufacturing and use of cannulae. Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=135644.%20)
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
FDA Clears Additive Orthopedics’ 3D Printed Lattice Plates
The patient-specific implants will be a component of the company’s integrated surgical planning system it plans to launch later in the year.
Gottlieb Says User Fees Will Pay for Post-Market Surveillance Amid Shutdown
FDA activities that most directly impact safety will continue “to the best of our abilities, subject to the legal and financial limitations of the current circumstances,” Gottlieb said.
